SCHEMBL18508704

SCHEMBL18508704

CCCC(C)(C)OC(=O)c1cc2[nH]cc(Cl)c2cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 14/20 0.37
GABRG2 P18507 14/20 0.37
GABRB3 P28472 14/20 0.37
GABRA3 P34903 14/20 0.37
GABRA2 P47869 14/20 0.37
GABRA5 P31644 13/20 0.37
GABRA6 Q16445 12/20 0.37
GABRA4 P48169 8/20 0.37
GABRP O00591 4/20 0.37
GABRD O14764 4/20 0.37
GABRB1 P18505 4/20 0.37
GABRB2 P47870 4/20 0.37
GABRE P78334 4/20 0.37
GABRG1 Q8N1C3 4/20 0.37
GABRG3 Q99928 4/20 0.37
GABRQ Q9UN88 4/20 0.37
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
CNR2 P34972 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18508705 0.85 GABRA1 (0.41) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL2806960 0.85 GABRG2 (0.50) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL4640037 0.68 NPC1 (0.35) MAPTSMN1; SMN2NPC1
SCHEMBL28819880 0.67 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL25007722 0.66 KDM4E (0.47) ALDH1A1MAPTSMN1; SMN2KDM4EHPGD
SCHEMBL28007337 0.66 GABRG2 (0.43) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL26625022 0.64 TDP1 (0.35) GABRA2GABRB2ALDH1A1MAPTKDM4E
SCHEMBL4640842 0.64 GRIN2D (0.33) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL4640807 0.64 CA1 (0.35) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL4640039 0.64 MEN1 (0.41) ALDH1A1SMN1; SMN2KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168952-B1 MORPHOLINE DERIVATIVES AS RENIN INHIBITORS MITSUBISHI TANABE PHARMA CORP (JP) 2017-02-15 EP disclosed